Clinical inertia with regard to intensifying therapy in people with type 2 diabetes treated with basal insulin

To investigate whether clinical inertia, the failure to intensify treatment regimens when required, exists in people with type 2 diabetes treated with basal insulin.

• Publication year

  2016

• Venue

  Diabetes, obesity and metabolism

• Publication date

  2016-02-09

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/dom.12626PMID 26743666PMCID 5067688
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Quality and Outcomes Framework: what have we learnt?

  2016cited by this paper
• Acknowledging and allocating responsibility for clinical inertia in the management of Type 2 diabetes in primary care: a qualitative study

  2015cited by this paper
• Delay in treatment intensification increases the risks of cardiovascular events in patients with type 2 diabetes

  2015cited by this paper
• Barriers to Initiating Insulin in Type 2 Diabetes Patients: Development of a New Patient Education Tool to Address Myths, Misconceptions and Clinical Realities

  2014cited by this paper
• Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes

  2014cited by this paper
• Clinical inertia in type 2 diabetes: A retrospective analysis of pharmacist-managed diabetes care vs. usual medical care

  2013cited by this paper
• Exploiting the potential of large databases of electronic health records for research using rapid search algorithms and an intuitive query interface

  2013cited by this paper
• Clinical Inertia during Postoperative Management of Diabetes Mellitus: Relationship between Hyperglycemia and Insulin Therapy Intensification

  2013cited by this paper
• Clinical Inertia in People With Type 2 Diabetes

  2013cited by this paper
• A retrospective cohort study of more than 80,000 people

  2013influential reference
• Intensification of Insulin Therapy for Type 2 Diabetic Patients in Primary Care: Basal-Bolus Regimen Versus Premix Insulin Analogs

  2013cited by this paper
• Insulin Therapy in Type 2 Diabetes Mellitus: A Practical Approach for Primary Care Physicians and Other Health Care Professionals

  2013cited by this paper
• Standards of Medical Care in Diabetes—2014

  2013cited by this paper
• Self‐titration of insulin in the management of people with type 2 diabetes: a practical solution to improve management in primary care

  2013cited by this paper
• Recent advances in the utility and use of the General Practice Research Database as an example of a UK Primary Care Data resource

  2012cited by this paper
• Insulin initiation and management in people with Type 2 diabetes in an ethnically diverse population: the healthcare provider perspective

  2012cited by this paper
• Study of Once Daily Levemir (SOLVE™): insights into the timing of insulin initiation in people with poorly controlled type 2 diabetes in routine clinical practice

  2012cited by this paper
• Risk identification and interventions to prevent type 2 diabetes in adults at high risk: summary of NICE guidance

  2012cited by this paper
• Miscoding, misclassification and misdiagnosis of diabetes in primary care

  2012cited by this paper
• Optimization of insulin therapy in patients with Type 2 diabetes mellitus: beyond basal insulin

  2012cited by this paper
• Deprescribing medication in very elderly patients with multimorbidity: the view of Dutch GPs. A qualitative study

  2012cited by this paper
• THERAPY OF ENDOCRINE DISEASE: Insulin initiation in patients with type 2 diabetes mellitus: treatment guidelines, clinical evidence and patterns of use of basal vs premixed insulin analogues

  2011cited by this paper
• Safety, efficacy and tolerability of exenatide in combination with insulin in the Association of British Clinical Diabetologists nationwide exenatide audit *

  2011cited by this paper
• Clinical inertia in management of T2DM.

  2010cited by this paper
• Validity of diagnostic coding within the General Practice Research Database: a systematic review.

  2010cited by this paper
• Defining and Characterizing the Progression of Type 2 Diabetes

  2009cited by this paper
• Three-year efficacy of complex insulin regimens in type 2 diabetes.

  2009cited by this paper
• Switching from premixed insulin to glargine-based insulin regimen improves glycaemic control in patients with type 1 or type 2 diabetes: a retrospective primary care-based analysis

  2009cited by this paper
• Glycemic Control in Diabetes: A Tale of Three Studies

  2008cited by this paper
• 10-year follow-up of intensive glucose control in type 2 diabetes.

  2008influential reference
• Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes.

  2007cited by this paper
• Delayed initiation of subcutaneous insulin therapy after failure of oral glucose‐lowering agents in patients with Type 2 diabetes: a population‐based analysis in the UK

  2007cited by this paper
• Standards of medical care in diabetes.

  2006cited by this paper
• Standards of Medical Care in Diabetes: Response to Power

  2006cited by this paper
• Risk of stroke in people with type 2 diabetes in the UK: a study using the General Practice Research Database

  2006cited by this paper
• Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem.

  2005cited by this paper
• The burden of treatment failure in type 2 diabetes.

  2004cited by this paper
• Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

  2000cited by this paper
• A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

  1987cited by this paper
• What are the barriers faced by patients using insulin? A qualitative study of Malaysian health care professionals’ views

  year unknowncited by this paper

• Predictors and Consequences of Delayed Insulin Initiation: A 20-year Retrospective Cohort Study on Diabetes Complications in Southern Thailand.

  2026cites this paper
• Overcoming Therapeutic Inertia with Inhaled Insulin Therapy

  2026cites this paper
• Current Status of Delay in Injectable Therapy among Type 2 Diabetes Mellitus Patients in South Korea: Multicenter Retrospective Study (2015–2021)

  2025cites this paper
• Achievement of HbA1c and weight targets in adults with type 2 diabetes on once weekly injectable glucagon‐like peptide‐1 receptor agonist therapy in UK primary care: A retrospective, real‐world study

  2025cites this paper
• Beta-cell preservation in T2DM using a pathophysiologic approach

  2025influential citation
• Clinical inertia and treatment intensification among patients with type ii diabetes mellitus at Debre Tabor comprehensive specialized hospital, Ethiopia: an institutional-based cross-sectional study

  2025cites this paper
• Incidence of treatment intensification based on HbA1c trends in people with type 2 diabetes

  2025cites this paper
• Treatment intensification strategies and metabolic outcomes in individuals with type 2 diabetes on GLP-1 RA therapy.

  2025cites this paper
• A real-world study assessing the efficacy and safety of switching from basal bolus insulin therapy to once daily iGlarLixi in people with type 2 diabetes mellitus: soli de-escalation.

  2025cites this paper
• Clinical Inertia in SGLT2 Inhibitor Use Among Elderly Patients with Type 2 Diabetes and Chronic Kidney Disease: A Comparison of Regional and University Hospital Practice

  2025cites this paper
• The safety of novel once-weekly insulins in the management of diabetes.

  2025cites this paper
• Missed opportunities in diabetes care: unraveling therapeutic inertia and its predictors in resource-limited settings

  2025cites this paper
• Use of Fixed Ratio Combinations to Improve Glycemic Control in Individuals with Type 2 Diabetes: Experts’ Opinion from the Gulf Region

  2025cites this paper
• What Is the Role of Basal Weekly Insulin in Clinical Practice? The State of the Art

  2024cites this paper
• Web-Based, Algorithm-Guided Insulin Titration in Insulin-Treated Type 2 Diabetes: Pre-Post Intervention Study

  2024cites this paper
• Once‐weekly insulin efsitora alfa: Design and rationale for the QWINT phase 3 clinical development programme

  2024cites this paper
• Real‐world effectiveness and safety of insulin glargine 100 U/mL plus lixisenatide in adults with type 2 diabetes: An international, multicentre, 12‐month, prospective observational study

  2024cites this paper
• Insulin Inertia Among People With Type 2 Diabetes Mellitus in Qatar: The INERT‐Q Study

  2024influential citation
• Continuous glucose monitoring for the routine care of type 2 diabetes mellitus

  2024cites this paper
• Opportunities to overcome underutilization of enhanced insulin delivery technologies in people with type 2 diabetes: a narrative review

  2024cites this paper
• Therapeutic inertia: a retrospective examination of inpatient management for type 2 diabetes mellitus at a South African regional hospital during a singular hospitalisation

  2024cites this paper
• Patient’s barrier to initiate insulin therapy for type 2 D.M.

  2024cites this paper
• Prioritizing Patient Experiences in the Management of Diabetes and Its Complications: An Endocrine Society Position Statement.

  2024cites this paper
• Kontinuierliche Glukosemessung bei Menschen mit Typ-2-Diabetes ohne intensivierte Insulintherapie: eine Standortbestimmung

  2024cites this paper
• Expert Opinion on Optimising Type 2 Diabetes Treatment Using Fixed-Ratio Combination of Basal Insulin and GLP-1 RA for Treatment Intensification and Simplification

  2024cites this paper
• Predictive value of postprandial C-peptide for utilizing multiple daily injection therapy in type 2 diabetes

  2024cites this paper
• Treatment intensification following glucagon-like peptide-1 receptor agonist in type 2 diabetes: Comparative effectiveness analyses between free vs. fixed combination of GLP-1 RA and basal insulin. RESTORE-G real-world study.

  2024cites this paper
• CURRENT TREATMENT APPROACHES AND GLYCEMIC CONTROL IN TURKISH PATIENTS WITH TYPE 2 DIABETES MELLITUS: A REAL-WORLD EVIDENCE FROM A TERTIARY HOSPITAL IN TURKEY.

  2024cites this paper
• Status of diabetes mellitus in different regions of KSA and update on its management

  2024cites this paper
• Modeling the Clinical and Economic Burden of Therapeutic Inertia in People with Type 2 Diabetes in Saudi Arabia

  2024cites this paper
• Open questions on basal insulin therapy in T2D: a Delphi consensus

  2024cites this paper
• Treatment intensification following glucagon-like peptide-1 receptor agonist treatment in type 2 diabetes: The RESTORE-G real-world study.

  2023cites this paper
• Saudi Consensus for Oral Semaglutide, the Recent Innovation in GLP-1 RAs Era; Consensus Report

  2023cites this paper
• Effect of delay in treatment intensification in people with type 2 diabetes and suboptimal glycaemia after basal insulin initiation: A real‐world observational study

  2023influential citation
• Efficacy of Insulin Titration Driven by SMS in Improving Glycemic Control in People with Type 2 Diabetes

  2023cites this paper
• Factors Associated with Attainment of Glycemic Targets Among Adults with Type 1 and Type 2 Diabetes in Canada: A Cross-Sectional Study Using Primary- and Specialty-Care Electronic Medical Record Data.

  2023cites this paper
• Early use of oral semaglutide in the UK: A cost-effectiveness analysis versus continuing metformin and SGLT-2 inhibitor therapy

  2023cites this paper
• Does fully closed‐loop automated insulin delivery improve glycaemic control in patients with type 2 diabetes? A meta‐analysis of randomized controlled trials

  2023cites this paper
• Quelle place de la diabétologie connectée pour les patients en multi-injections d'insuline ?

  2023cites this paper
• Expanding the Role of Continuous Glucose Monitoring in Modern Diabetes Care Beyond Type 1 Disease

  2023cites this paper
• Therapeutic Inertia and Delays in Insulin Intensification in Type 2 Diabetes: A Literature Review

  2023influential citation
• Descriptive study of a clinical and educational telemedicine intervention in patients with diabetes receiving glargine 300 U/ml (Toujeo) in Spain: results of the T-Coach programme

  2023cites this paper
• Diabetes Management and Outcomes among Patients with Type 2 Diabetes Attending a Renal Service

  2023cites this paper
• Use of smartphone application versus written titration charts for basal insulin titration in adults with type 2 diabetes and suboptimal glycaemic control (My Dose Coach): multicentre, open-label, parallel, randomised controlled trial

  2023cites this paper
• Real-World Patterns of Basal Insulin Use with Other Diabetes Medications Among People with Type 2 Diabetes Between 2014 and 2020

  2023cites this paper
• Feasibility and acceptability of the use of flash glucose monitoring encountered by Indigenous Australians with type 2 diabetes mellitus: initial experiences from a pilot study

  2023cites this paper
• Telehealth Intervention to Improve Uptake of Evidence-Based Medications among Patients with Type 2 Diabetes and Heart Failure or Cardiovascular Disease

  2023cites this paper
• Factors associated with therapeutic inertia in individuals with type 2 diabetes mellitus started on basal insulin

  2023cites this paper
• Personalized Virtual Care Using Continuous Glucose Monitoring in Adults With Type 2 Diabetes Treated With Less Intensive Therapies

  2023cites this paper
• Evaluation of a Digital Health Tool for Titration of Basal Insulin in People With Type 2 Diabetes: Rationale and Design of a Randomized Controlled Trial

  2023cites this paper
• Flash glucose monitoring in type 2 diabetes managed with basal insulin in the USA: a retrospective real-world chart review study and meta-analysis

  2022cites this paper
• Real-Time Flash Glucose Monitoring Had Better Effects on Daily Glycemic Control Compared With Retrospective Flash Glucose Monitoring in Patients With Type 2 Diabetes on Premix Insulin Therapy

  2022cites this paper
• Inequalities in access to community-based diabetes examination and its impact on healthcare utilization among middle-aged and older adults with diabetes in China

  2022cites this paper
• The long-term cost-effectiveness of oral semaglutide versus empagliflozin and dulaglutide in Portugal

  2022cites this paper
• Clinical Inertia in the Management of Type 2 Diabetes Mellitus: A Systematic Review

  2022cites this paper
• Cutaneous diphtheria causing diabetic foot ulcer infection: A case report

  2022cites this paper
• Barriers and Facilitators to the Initiation of Injectable Therapies for Type 2 Diabetes Mellitus: A Mixed Methods Study

  2022cites this paper
• Transitioning from basal–bolus or premix insulin therapy to a combination of basal insulin and glucagon‐like peptide‐1 receptor agonist in people with type 2 diabetes

  2022cites this paper
• Cost-Effectiveness of iGlarLixi Versus Premix BIAsp 30 in People with Type 2 Diabetes Suboptimally Controlled by Basal Insulin in the US

  2022cites this paper
• Glycemic control in newly insulin-initiated patients with type 2 diabetes mellitus: A retrospective follow-up study at a university hospital in Ethiopia

  2022cites this paper
• Time for Using Machine Learning for Dose Guidance in Titration of People With Type 2 Diabetes? A Systematic Review of Basal Insulin Dose Guidance

  2022cites this paper
• Nghiên cứu nồng độ glucose máu trước khi ngủ ở bệnh nhân đái tháo đường típ 2 được điều trị bằng liệu pháp insulin

  2022cites this paper
• Trends in Timing of and Glycemia at Initiation of Second-line Type 2 Diabetes Treatment in U.S. Adults.

  2022cites this paper
• New digital health technologies for insulin initiation and optimization for people with type 2 diabetes.

  2022cites this paper
• Expert Panel Guidance and Narrative Review of Treatment Simplification of Complex Insulin Regimens to Improve Outcomes in Type 2 Diabetes

  2022cites this paper
• Clinical decision support systems with team-based care on type 2 diabetes improvement for Medicaid patients: A quality improvement project

  2021cites this paper
• Identification of the Inappropriate Clinical Actions (DON'T) to Improve the Management of Patients with Type 2 Diabetes Failing Basal Insulin Supported Oral Treatment: Results of Survey for a Panel of Diabetes Specialists in Italy

  2021cites this paper
• Ultra‐rapid‐acting insulins for adults with diabetes: A systematic review and meta‐analysis

  2021cites this paper
• Machine Learning Approaches to Predict Risks of Diabetic Complications and Poor Glycemic Control in Nonadherent Type 2 Diabetes

  2021cites this paper
• Ethnic, social and multimorbidity disparities in therapeutic inertia: A UK primary care observational study in patients newly diagnosed with type 2 diabetes

  2021cites this paper
• Initiation of four basal insulins and subsequent treatment modification in people treated for type 2 diabetes in the United Kingdom: Changes over the period 2003–2018

  2021cites this paper
• Use of Computerized Insulin Dose Adjustment Algorithms to Facilitate Adjusting Insulin Doses by Primary Care Providers

  2021cites this paper
• Effect of Diabetes-Trained Nurse Practitioners on Glycemic Outcomes: Their Suggested Use in Busy Primary Care Practices

  2021cites this paper
• One in Seven Insulin-Treated Patients in Developing Countries Reported Poor Persistence with Insulin Therapy: Real World Evidence from the Cross-Sectional International Diabetes Management Practices Study (IDMPS)

  2021cites this paper
• Titratable fixed‐ratio combination of basal insulin plus a glucagon‐like peptide‐1 receptor agonist: A novel, simplified alternative to premix insulin for type 2 diabetes

  2021cites this paper
• A Pragmatic Study of Basal and Mid-Mixture Insulins as Starter Insulins in Chinese Patients With Type 2 Diabetes: Observations From Long-Term, Real-World Experience

  2021cites this paper
• Therapeutic inertia in the management of dyslipidaemia and hypertension in incident type 2 diabetes and the resulting risk factor burden: Real‐world evidence from primary care

  2021cites this paper
• The long-term cost-effectiveness of oral semaglutide in the Netherlands based on the PIONEER 2, 3 and 4 randomized controlled trials.

  2021cites this paper
• Effectiveness of Ginger in the Treatment of Type 2 Diabetes Mellitus: A Pilot Study of the Randomized Clinical Trial Type

  2021cites this paper
• Overcoming Therapeutic Inertia in the Age of Advanced Diabetes Medication Therapy and Technology

  2021influential citation
• Therapeutic inertia in patients with type 2 diabetes treated with non-insulin agents.

  2021cites this paper
• Comparing Patch vs Pen Bolus Insulin Delivery in Type 2 Diabetes Using Continuous Glucose Monitoring Metrics and Profiles

  2021cites this paper
• A Retrospective Analysis of Therapeutic Inertia in Type 2 Diabetes Management Across a Diverse Population of Health Care Organizations in the USA

  2021cites this paper
• Delphi-Based Consensus on Treatment Intensification in Type 2 Diabetes Subjects Failing Basal Insulin Supported Oral Treatment: Focus on Basal Insulin + GLP-1 Receptor Agonist Combination Therapies

  2021cites this paper
• Overview of Therapeutic Inertia in Diabetes: Prevalence, Causes, and Consequences

  2020cites this paper
• Therapeutic Inertia in People With Type 2 Diabetes in Primary Care: A Challenge That Just Won’t Go Away

  2020cites this paper
• FROM RESEARCH TO PRACTICE Overview of Therapeutic Inertia in Diabetes: Prevalence, Causes, and Consequences

  2020cites this paper
• The burden of type 2 diabetes in Europe: current and future aspects of insulin treatment from patient and healthcare spending perspectives.

  2020cites this paper
• Comparable efficacy with similarly low risk of hypoglycaemia in patient‐ vs physician‐managed basal insulin initiation and titration in insulin‐naïve type 2 diabetic subjects: The Italian Titration Approach Study

  2020cites this paper
• Impact of Simultaneous Versus Sequential Initiation of Basal Insulin and Glucagon-like Peptide-1 Receptor Agonists on HbA1c in Type 2 Diabetes: A Retrospective Observational Study

  2020cites this paper
• Ultra Rapid-Acting Inhaled Insulin Improves Glucose Control in Patients With Type 2 Diabetes Mellitus.

  2020cites this paper
• Persistent poor glycaemic control in individuals with type 2 diabetes in developing countries: 12 years of real-world evidence of the International Diabetes Management Practices Study (IDMPS)

  2020cites this paper
• Evaluation of the Clinical and Economic Burden of Poor Glycemic Control Associated with Therapeutic Inertia in Patients with Type 2 Diabetes in the United States

  2020cites this paper
• Feasibility of a New Approach to Initiate Insulin in Type 2 Diabetes

  2020cites this paper
• Oral semaglutide versus injectable glucagon-like peptide-1 receptor agonists: a cost of control analysis

  2020cites this paper
• Third-Line Antidiabetic Therapy Intensification Patterns and Glycaemic Control in Patients with Type 2 Diabetes in the USA: A Real-World Study

  2020cites this paper
• Insulin Therapy in Type 2 Diabetes.

  2020cites this paper
• Glucagon-like-1 receptor agonists and sodium/glucose cotransporter-2 inhibitors combination—are we exploiting their full potential in a real life setting?

  2020cites this paper
• Glycaemic profiles of diverse patients with type 2 diabetes using basal insulin: MOBILE study baseline data

  2020cites this paper
• The Lancet Commission on diabetes: using data to transform diabetes care and patient lives.

  2020cites this paper